|
|
作者（Authors）
|
文章標題（Article Title）
|
期刊（Journal）
|
|
1
|
Hsu JY, Wu UI*, Wang JT, Sheng WH, Chen YC, Chang SC
|
Managing Helicobacter pylori as an Infectious Disease: Implementation of Antimicrobial Stewardship
|
Helicobacter. 2025 Jan-Feb;30(1):e70013.
|
|
2
|
Hsu JY, Chiang SO, Yang CC, Mao YC*.
|
A Nationwide Study on the Risks of Complications and Healthcare Costs of Snakebite Envenomation in Taiwan.
|
Am J Trop Med Hyg. 2024 May 7:tpmd240030.
|
|
3
|
Hsu JY, Chu FY, Wang PH, Wu ML*.
|
Unusual hard metal lung disease: bronchiolocentric interstitial pneumonia.
|
Occup Med (Lond). 2024 May 3:kqae030.
|
|
4
|
Hsu JY, Sun HY, Chen LY, Chang SY, Chuang YC, Huang YS, Su YC, Liu WC, Hung CC*.
|
Weight and metabolic changes among virally suppressed people with HIV who switched to co-formulated bictegravir/emtricitabine/tenofovir alafenamide.
|
J Glob Antimicrob Resist. 2024 Mar;36:426-435.
|
|
5
|
Hsieh CY, Hsu JY, Yang CC*.
|
Predictive factors for severe outcomes in substance abuse-related emergency visits: A 5-year retrospective analysis at a medical center in Taiwan.
|
J Chin Med Assoc. 2024 Jan 1;87(1):40-47.
|
|
6
|
Hsu JY*, Hung CC, Tsou TP, Chen WC.
|
Epidemiology and risk factors of Japanese encephalitis in Taiwan, 2010-2022.
|
PLoS Negl Trop Dis. 2023 Oct 2;17(10):e0011421.
|
|
7
|
Hsu JY, Chiang SO, Yang CC, Hsieh TW, Chung CJ, Mao YC*.
|
Nationwide and long-term epidemiological research of snakebite envenomation in Taiwan during 2002-2014 based on the use of snake antivenoms: A study utilizing National Health Insurance Database.
|
PLoS Negl Trop Dis. 2023 Jun 8;17(6):e0011376.
|
|
8
|
Hsu JY, Sun HY, Hsieh TW, Chang SY, Chuang YC, Huang YS, Hsiao CY, Su YC, Liu WC, Chang SF, Hung CC*.
|
Incidence of low-level viremia and its impact on virologic failure among people living with HIV-1 who switched to elvitegravir-based antiretroviral therapy.
|
J Glob Antimicrob Resist. 2022 Jun;29:7-16.
|
|
9
|
Hsu JY, Cheng A, Ku CC, Chen YC, Wang JT, Hsieh TW, Sheng WH, Chang SC, Wu UI*.
|
Mycobacterium abscessus and Mycobacterium massiliense exhibit distinct host and organ specificity: a cross-sectional study.
|
Int J Infect Dis. 2022 Mar;116:21-26.
|
|
10
|
Hsu JY, Liu PY, Tseng CH, Liu CW, Yang WT, Huang WH, Li SY, Liao YC, Wu MJ*.
|
COVID-19 Screening for Hospitalized Patients: The Role of Expanded Hospital Surveillance in a Low Prevalence Setting.
|
J Multidiscip Healthc. 2021 Oct 27;14:3027-3034.
|
|
11
|
Hsu JY, Mao YC, Liu PY*, Lai KL*.
|
Pharmacology and Adverse Events of Emergency-Use Authorized Medication in Moderate to Severe COVID-19.
|
Pharmaceuticals (Basel). 2021 Sep 23;14(10):955.
|
|
12
|
Hsu JY, Chuang YC, Wang JT, Chen YC, Hsieh SM*.
|
Healthcare-associated carbapenem-resistant Klebsiella pneumoniae bloodstream infections: Risk factors, mortality, and antimicrobial susceptibility, 2017-2019.
|
J Formos Med Assoc. 2021 Nov;120(11):1994-2002.
|